Retrovirus-mediated IL-7 expression in leukemic dendritic cells generated from primary acute myelogenous leukemias enhances their functional properties.
暂无分享,去创建一个
Walter Knapp | W. Knapp | M. Buschle | N. Carballido‐Perrig | J. Carballido | Michael Buschle | Jana Stasakova | Concha Bello-Fernández | Alexander Renner | Nicole Carballido-Perrig | Margit Koening | Martina Waclavicek | Otto Madjic | Leopold Oehler | Oskar Haas | José M Carballido | M. Waclavicek | J. Stasakova | L. Oehler | C. Bello‐Fernandez | Oskar Haas | Alexander Renner | Margit Koening | Otto Madjic | Oskar A. Haas
[1] R. Foà,et al. CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells. , 1999, Blood.
[2] M. Lotze,et al. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12. , 1999, Cancer research.
[3] T. Luger,et al. Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacity. , 1999, Journal of immunology.
[4] H. Young,et al. IL-7 regulation of cytotoxic lymphocytes: pore-forming protein gene expression, interferon-gamma production, and cytotoxicity of human peripheral blood lymphocytes subsets. , 1991, Cellular immunology.
[5] A. Dietz,et al. High efficiency adenovirus-mediated gene transfer to human dendritic cells. , 1998, Blood.
[6] E. Jaffee,et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[7] A. Hagemeijer,et al. A DNA probe combination for improved detection of MLL/11q23 breakpoints by double‐color interphase‐FISH in acute leukemias , 2000, Genes, chromosomes & cancer.
[8] C. Eaves,et al. Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures. , 1992, The Journal of clinical investigation.
[9] O. Majdic,et al. Efficient retrovirus-mediated gene transfer of dendritic cells generated from CD34+ cord blood cells under serum-free conditions. , 1997, Human gene therapy.
[10] C. Wilson,et al. Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha. , 1998, Journal of immunology.
[11] E. Vellenga,et al. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1. , 1997, Blood.
[12] G. Gray,et al. The role of B7 costimulation by murine acute myeloid leukemia in the generation and function of a CD8+ T-cell line with potent in vivo graft-versus-leukemia properties. , 1997, Blood.
[13] B. Dörken,et al. Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells. , 1997, Experimental hematology.
[14] R. Foà,et al. Transduction of the IL2 gene into human acute leukemia cells: induction of tumor rejection without modifying cell proliferation and IL2 receptor expression. , 1994, Journal of the National Cancer Institute.
[15] K. Weinberg,et al. Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage- colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses. , 2000, Blood.
[16] S. Jameson,et al. Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo , 2000, Nature Immunology.
[17] T. Fry,et al. Interleukin-7: master regulator of peripheral T-cell homeostasis? , 2001, Trends in immunology.
[18] R. Champlin,et al. Dendritic Cells Derived In Vitro From Acute Myelogenous Leukemia Cells Stimulate Autologous, Antileukemic T-Cell Responses , 1999 .
[19] S. Reed,et al. Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells , 1989, The Journal of experimental medicine.
[20] G. Freeman,et al. Role of B7-1 in mediating an immune response to myeloid leukemia cells. , 1995, Blood.
[21] A. Hindenburg,et al. Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia , 1994 .
[22] B. Dörken,et al. Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activation , 1998, Gene Therapy.
[23] Thomas,et al. Monocyte‐derived dendritic cells do not proliferate and are not susceptible to retroviral transduction , 2000, British journal of haematology.
[24] D. Postma,et al. IL-7 differentially modulates the expression of IFN-gamma and IL-4 in activated human T lymphocytes by transcriptional and post-transcriptional mechanisms. , 1996, Journal of immunology.
[25] J. Leonard,et al. Vaccines with interleukin-12-transduced acute myeloid leukemia cells elicit very potent therapeutic and long-lasting protective immunity. , 1999, Blood.
[26] M. Sadelain,et al. Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacity. , 1997, Blood.
[27] D. Pardoll,et al. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. , 1991, Science.
[28] G. Dranoff,et al. Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines. , 1998, Blood.
[29] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[30] D. Schadendorf,et al. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation , 1995, European journal of immunology.
[31] B. Quesnel,et al. Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein , 1999, Gene Therapy.
[32] Robert E. Miller,et al. Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo , 1994, The Journal of experimental medicine.
[33] H. Koeffler,et al. Immunotherapy against murine leukemia , 1998, Leukemia.
[34] E. Gilboa,et al. Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity , 1990, The Journal of experimental medicine.
[35] M L Brereton,et al. Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia. , 2001, Blood.
[36] F. Farzaneh,et al. Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7.1 , 1997, Gene Therapy.
[37] B. Cocks,et al. Reversal of human allergic T helper 2 responses by engagement of signaling lymphocytic activation molecule. , 1997, Journal of immunology.
[38] R. Arceci,et al. Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML. , 1996, Blood.
[39] T. Fry,et al. Interleukin-7 restores immunity in athymic T-cell-depleted hosts. , 2001, Blood.
[40] M. Salmon,et al. IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire. , 1998, Journal of immunology.
[41] T. Lövgren,et al. Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence. , 1986, Journal of immunological methods.